|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goncalves A, Fabbro M, Lhommé C, Gladieff
L, Extra JM, Floquet A, Chaigneau L, Carrasco AT and Viens P: A
phase II trial to evaluate gefitinib as second- or third-line
treatment in patients with recurring locoregionally advanced or
metastatic cervical cancer. Gynecol Oncol. 108:42–46. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Elit LM and Hirte H: Management of
advanced or recurrent cervical cancer: Chemotherapy and beyond.
Expert Rev Anticancer Ther. 14:319–332. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
National Comprehensive Cancer Network
(NCCN): NCCN Clinical Practice Quidelines in Oncology: Cervical
Cancer. version 2. 2015 http://www.nccn.org/professionals/physician_gls/f_guidelines.aspAccessed.
March 11–2017.
|
|
5
|
Monk BJ, Sill MW, McMeekin DS, Cohn DE,
Ramondetta LM, Boardman CH, Benda J and Cella D: Phase III trial of
four cisplatin-containing doublet combinations in stage IVB,
recurrent, or persistent cervical carcinoma: A gynecologic oncology
group study. J Clin Oncol. 27:4649–4655. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moore DH, Blessing JA, McQuellon RP,
Thaler HT, Cella D, Benda J, Miller DS, Olt G, King S, Boggess JF
and Rocereto TF: Phase III study of cisplatin with or without
paclitaxel in stage IVB, recurrent, or persistent squamous cell
carcinoma of the cervix: A gynecologic oncology group study. J Clin
Oncol. 22:3113–3119. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Japan Clinical Oncology Group, . Toita T,
Ohno T, Kaneyasu Y, Uno T, Yoshimura R, Kodaira T, Furutani K,
Kasuya G, Ishikura S, et al: A consensus-based guideline defining
the clinical target volume for pelvic lymph nodes in external beam
radiotherapy for uterine cervical cancer. Jpn J Clin Oncol.
40:456–463. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gu X, Yin W, Hu Y, et al: Tumor radiation
therapy. Pecking Union Medical College Press; Beijing: 2007
|
|
9
|
Toita T, Kitagawa R, Hamano T, Umayahara
K, Hirashima Y, Aoki Y, Oguchi M, Mikami M and Takizawa K: Cervical
Cancer (Vulva Cancer) Committee of Japanese Gynecologic Oncology
Group (JGOG): Phase II study of concurrent chemoradiotherapy with
high-dose-rate intracavitary brachytherapy in patients with locally
advanced uterine cervical cancer: Efficacy and toxicity of a low
cumulative radiation dose schedule. Gynaecol Oncol. 126:211–216.
2012. View Article : Google Scholar
|
|
10
|
Sharma DN, Subramani V, Rath GK, Ganesh T,
Julka PK, Basu Jyothi KS, Bahl A and Gopishankar N: Interstitial
brachytherapy guided intensity modulated radiation therapy in
cervical cancer: A dosimetric study. Int J Radiation Oncol Biol
Phys. 69:(Suppl). S731–S732. 2007. View Article : Google Scholar
|
|
11
|
Shi L, Wu C, Wu J, Zhou W, Ji M, Zhang H,
Zhao J, Huang Y, Pei H, Li Z, et al: Computed tomography-guided
permanent brachytherapy for locoregional recurrent gastric cancer.
Radiat Oncol. 7:1142012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang J, Jiang Y, Li J, Tian S, Ran W and
Xiu D: Intraoperative ultrasound-guided iodine-125 seed
implantation for unresectable pancreatic carcinoma. J Exp Clin
Cancer Res. 28:882009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nag S, Ellis RJ, Merrick GS, Bahnson R,
Wallner K and Stock R: American Brachytherapy Society: American
brachytherapy society recommendations for reporting morbidity after
prostate brachytherapy. Int J Radiat Biol Phys. 54:462–470. 2002.
View Article : Google Scholar
|
|
14
|
Yao L, Wang J, Jiang Y, Li J, Lin L, Ran W
and Liu C: Permanent interstitial 125I seed implantation as a
salvage therapy for pediatric recurrent or metastatic soft tissue
sarcoma after multidisciplinary treatment. World J Surg Oncol.
13:3352015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
